Time-dependent transcriptional induction of CYP1A1, CYP1A2 and CYP1B1 mRNAs by H+/K+ -ATPase inhibitors and other xenobiotics.

Article Details

Citation

Krusekopf S, Roots I, Hildebrandt AG, Kleeberg U

Time-dependent transcriptional induction of CYP1A1, CYP1A2 and CYP1B1 mRNAs by H+/K+ -ATPase inhibitors and other xenobiotics.

Xenobiotica. 2003 Feb;33(2):107-18.

PubMed ID
12623754 [ View in PubMed
]
Abstract

1. Xenobiotic-mediated regulation of mRNA expression of all members of the human cytochrome P450 (CYP) 1 family has been measured by RT-PCR in the hepatoma cell line, HepG2. Besides the positive control beta -naphthoflavone, the H(+)/K(+)-ATPase inhibitors omeprazole, lansoprazole, pantoprazole and rabeprazole and the anti-malaria drug primaquine were included in this study. 2. beta-Naphthoflavone, primaquine, omeprazole and lansoprazole increased mRNA levels of CYP1A1, CYP1A2 and CYP1B1. Induction by rabeprazole was significant only for CYP1A1 and CYP1A2, whereas none of the CYP1 mRNAs was induced by pantoprazole. This result was confirmed in primary human hepatocytes. 3. Transcriptional regulation was proved by inhibition of induction with actinomycin D. 4. Increase of CYP1 mRNA was significant after 1 h and maximal after 4 h. CYP1B1, but not CYP1A1 or CYP1A2, was dramatically down-regulated between 4 and 24 h. This decrease was prevented by treatment of cells with actinomycin D after induction, indicating an active transcription-dependent mechanism of CYP1B1 mRNA degradation. 5. In conclusion, xenobiotics inducing CYP1A1 mRNA expression have been shown also to induce CYP1A2 and CYP1B1, differing only with regard to level and time course of induction.

DrugBank Data that Cites this Article

Drug Enzymes
DrugEnzymeKindOrganismPharmacological ActionActions
LansoprazoleCytochrome P450 1A1ProteinHumans
Unknown
Inducer
Details
LansoprazoleCytochrome P450 1B1ProteinHumans
Unknown
Inducer
Details
OmeprazoleCytochrome P450 1A2ProteinHumans
Unknown
Inducer
Details
OmeprazoleCytochrome P450 1B1ProteinHumans
Unknown
Inducer
Details
PrimaquineCytochrome P450 1A1ProteinHumans
Unknown
Inducer
Details
PrimaquineCytochrome P450 1A2ProteinHumans
Unknown
Substrate
Inducer
Details
PrimaquineCytochrome P450 1B1ProteinHumans
Unknown
Inducer
Details
RabeprazoleCytochrome P450 1A1ProteinHumans
Unknown
Inducer
Details
RabeprazoleCytochrome P450 1A2ProteinHumans
Unknown
Inhibitor
Inducer
Details
Pharmaco-transcriptomics
DrugDrug GroupsGeneGene IDChangeInteractionChromosome
beta-NaphthoflavoneExperimentalCYP1A11543
upregulated
beta-Naphthoflavone results in increased expression of CYP1A1 mRNA15q24.1
beta-NaphthoflavoneExperimentalCYP1A21544
upregulated
beta-Naphthoflavone results in increased expression of CYP1A2 mRNA15q24.1
beta-NaphthoflavoneExperimentalCYP1B11545
upregulated
beta-Naphthoflavone results in increased expression of CYP1B1 mRNA2p22.2
LansoprazoleApproved InvestigationalCYP1A11543
upregulated
Lansoprazole results in increased expression of CYP1A1 mRNA15q24.1
LansoprazoleApproved InvestigationalCYP1A21544
upregulated
Lansoprazole results in increased expression of CYP1A2 mRNA15q24.1
LansoprazoleApproved InvestigationalCYP1B11545
upregulated
Lansoprazole results in increased expression of CYP1B1 mRNA2p22.2
OmeprazoleApproved Investigational Vet ApprovedCYP1A11543
upregulated
Omeprazole results in increased expression of CYP1A1 mRNA15q24.1
OmeprazoleApproved Investigational Vet ApprovedCYP1A21544
upregulated
Omeprazole results in increased expression of CYP1A2 mRNA15q24.1
OmeprazoleApproved Investigational Vet ApprovedCYP1B11545
upregulated
Omeprazole results in increased expression of CYP1B1 mRNA2p22.2
PrimaquineApprovedCYP1A11543
upregulated
Primaquine results in increased expression of CYP1A1 mRNA15q24.1
PrimaquineApprovedCYP1A21544
upregulated
Primaquine results in increased expression of CYP1A2 mRNA15q24.1
PrimaquineApprovedCYP1B11545
upregulated
Primaquine results in increased expression of CYP1B1 mRNA2p22.2
RabeprazoleApproved InvestigationalCYP1A11543
upregulated
Rabeprazole results in increased expression of CYP1A1 mRNA15q24.1
RabeprazoleApproved InvestigationalCYP1A21544
upregulated
Rabeprazole results in increased expression of CYP1A2 mRNA15q24.1